These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 34157166)

  • 41. COVID-19-associated pulmonary aspergillosis (CAPA): Risk factors and development of a predictive score for critically ill COVID-19 patients.
    Calderón-Parra J; Mills-Sanchez P; Moreno-Torres V; Tejado-Bravo S; Romero-Sánchez I; Balandin-Moreno B; Calvo-Salvador M; Portero-Azorín F; García-Masedo S; Muñez-Rubio E; Ramos-Martinez A; Fernández-Cruz A;
    Mycoses; 2022 May; 65(5):541-550. PubMed ID: 35212030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Covid-19-associated pulmonary aspergillosis in mechanically ventilated patients: incidence and outcome in a French multicenter observational cohort (APICOVID).
    Desmedt L; Raymond M; Le Thuaut A; Asfar P; Darreau C; Reizine F; Colin G; Auchabie J; Lorber J; La Combe B; Kergoat P; Hourmant B; Delbove A; Frérou A; Morin J; Ergreteau PY; Seguin P; Martin M; Reignier J; Lascarrou JB; Canet E
    Ann Intensive Care; 2024 Jan; 14(1):17. PubMed ID: 38285382
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis.
    Lamoth F; Lewis RE; Walsh TJ; Kontoyiannis DP
    J Infect Dis; 2021 Nov; 224(10):1631-1640. PubMed ID: 33770176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study.
    Kim SH; Hong JY; Bae S; Lee H; Wi YM; Ko JH; Kim B; Joo EJ; Seok H; Shi HJ; Yoo JR; Hyun M; Kim HA; Jang S; Mun SJ; Kim J; Kim MC; Jung DS; Kim SH; Peck KR
    J Korean Med Sci; 2022 May; 37(18):e134. PubMed ID: 35535369
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiology and Incidence of COVID-19-Associated Pulmonary Aspergillosis (CAPA) in a Greek Tertiary Care Academic Reference Hospital.
    Paramythiotou E; Dimopoulos G; Koliakos N; Siopi M; Vourli S; Pournaras S; Meletiadis J
    Infect Dis Ther; 2021 Sep; 10(3):1779-1792. PubMed ID: 34260038
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study.
    Hatzl S; Reisinger AC; Posch F; Prattes J; Stradner M; Pilz S; Eller P; Schoerghuber M; Toller W; Gorkiewicz G; Metnitz P; Rief M; Prüller F; Rosenkranz AR; Valentin T; Krause R; Hoenigl M; Schilcher G
    Crit Care; 2021 Sep; 25(1):335. PubMed ID: 34526087
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19).
    Dupont D; Menotti J; Turc J; Miossec C; Wallet F; Richard JC; Argaud L; Paulus S; Wallon M; Ader F; Persat F
    Med Mycol; 2021 Jan; 59(1):110-114. PubMed ID: 32914189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina.
    Giusiano G; Fernández NB; Vitale RG; Alvarez C; Ochiuzzi ME; Santiso G; Cabeza MS; Tracogna F; Farías L; Afeltra J; Noblega LM; Giuliano CV; Garcia-Effron G
    Med Mycol; 2022 May; 60(5):. PubMed ID: 35394043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lateral flow assay (LFA) in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a single-center experience.
    Serin I; Baltali S; Cinli TA; Goze H; Demir B; Yokus O
    BMC Infect Dis; 2022 Nov; 22(1):822. PubMed ID: 36348480
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians.
    Lamoth F
    Curr Opin Infect Dis; 2022 Apr; 35(2):163-169. PubMed ID: 34980831
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study.
    Lahmer T; Kriescher S; Herner A; Rothe K; Spinner CD; Schneider J; Mayer U; Neuenhahn M; Hoffmann D; Geisler F; Heim M; Schneider G; Schmid RM; Huber W; Rasch S
    PLoS One; 2021; 16(3):e0238825. PubMed ID: 33730058
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of influenza- and COVID-19-associated pulmonary aspergillosis in China.
    Zhao J; Zhuo X; Pu D; Fan G; Lu B; Cao B
    Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):683-692. PubMed ID: 38326545
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Invasive pulmonary aspergillosis in patients with acute respiratory syndrome by COVID-19.
    Sánchez Martín C; Madrid Martínez E; González Pellicer R; Armero Ibáñez R; Martínez González E; Llau Pitarch JV
    Rev Esp Anestesiol Reanim (Engl Ed); 2022 Jan; 69(1):48-53. PubMed ID: 35033481
    [TBL] [Abstract][Full Text] [Related]  

  • 54. COVID-19-associated pulmonary aspergillosis in a tertiary care center in Shenzhen City.
    Jiang Z; Chen S; Zhu Q; Xiao Y; Qu J
    J Infect Public Health; 2022 Feb; 15(2):222-227. PubMed ID: 35032951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coronavirus Disease 2019-Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients.
    Permpalung N; Chiang TP; Massie AB; Zhang SX; Avery RK; Nematollahi S; Ostrander D; Segev DL; Marr KA
    Clin Infect Dis; 2022 Jan; 74(1):83-91. PubMed ID: 33693551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [COVID-19-associated pulmonary aspergillosis in critically ill patients: experience of a Chilean public hospital].
    Araya-Rojas F; Lasso-Barreto M
    Rev Chilena Infectol; 2021 Dec; 38(6):754-760. PubMed ID: 35506848
    [TBL] [Abstract][Full Text] [Related]  

  • 57. COVID-19-associated pulmonary aspergillosis in patients with severe SARS-CoV-2 infection: A single-center observational study from Greece.
    Ouranos K; Tsakiri K; Massa E; Dourliou V; Mouratidou C; Soundoulounaki S; Mouloudi E
    Ann Thorac Med; 2023; 18(3):116-123. PubMed ID: 37663880
    [TBL] [Abstract][Full Text] [Related]  

  • 58. COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants.
    Bay P; Audureau E; Préau S; Favory R; Guigon A; Heming N; Gault E; Pham T; Chaghouri A; Turpin M; Morand-Joubert L; Jochmans S; Pitsch A; Meireles S; Contou D; Henry A; Joseph A; Chaix ML; Uhel F; Roux D; Descamps D; Emery M; Garcia-Sanchez C; Levy D; Burrel S; Mayaux J; Kimmoun A; Hartard C; Pène F; Rozenberg F; Gaudry S; Brichler S; Guillon A; Handala L; Tamion F; Moisan A; Daix T; Hantz S; Delamaire F; Thibault V; Souweine B; Henquell C; Picard L; Botterel F; Rodriguez C; Dessap AM; Pawlotsky JM; Fourati S; de Prost N;
    Ann Intensive Care; 2024 Apr; 14(1):65. PubMed ID: 38658426
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Challenges in Diagnosing COVID-19-Associated Pulmonary Aspergillosis in Critically Ill Patients: The Relationship between Case Definitions and Autoptic Data.
    Casalini G; Giacomelli A; Galimberti L; Colombo R; Ballone E; Pozza G; Zacheo M; Galimberti M; Oreni L; Carsana L; Longo M; Gismondo MR; Tonello C; Nebuloni M; Antinori S
    J Fungi (Basel); 2022 Aug; 8(9):. PubMed ID: 36135619
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COVID-19 associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit: Impact of Antifungal Prophylaxis.
    Frost J; Gornicec M; Reisinger AC; Eller P; Hoenigl M; Prattes J
    Mycopathologia; 2024 Jan; 189(1):3. PubMed ID: 38217742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.